| General Information of Drug Metabolite (DM) (ID: DM002492) |
| DM Name |
Asunaprevir metabolite M9
|
|
|
|
|
|
|
|
| Full List of Drug-Metabolizing Enzyme (DME) Related to This DM |
| DME(s) Producing This DM through Metabolism |
| DME Name |
DME ID |
Reactant |
Reaction |
Related Drug |
REF |
|
Cytochrome P450 3A4 (CYP3A4)
|
DME0001
|
| Oxidation - Oxidation |
BMS-650032
|
[1] , [2] |
|
Cytochrome P450 3A5 (CYP3A5)
|
DME0012
|
| Oxidation - Oxidation |
BMS-650032
|
[1] , [2] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Full List of Drug(s) That Produce This DM By Metabolism |
| BMS-650032 |
DR0148
|
Phase 3 |
Viral hepatitis |
|
|
| References |
| 1 |
Effect of CYP3A5*3 genetic variant on the metabolism of direct-acting antivirals in vitro: a different effect on asunaprevir versus daclatasvir and beclabuvir J Hum Genet. 2020 Jan;65(2):143-153. doi: 10.1038/s10038-019-0685-2.
|
| 2 |
DrugBank(Pharmacology-Metabolism)Asunaprevir
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.
